Filter Results :

Your search for Cancer returned 1039 reports

Sort by


Global Cancer Immunotoxins Market & Clinical Pipeline Insight 2020

22 Jul 2016  |  Published by:  KuicK Research
Immunotoxins are new generation chemotherapeutic agents innovated to include the specificity of monoclonal antibody and cytotoxicity of toxins extracted from plant or bacterial source. The targeting moiety carries the specificity of the antibody and is directed to the target where it either bi...

$ 2,400.00

Read More

Breast Cancer Screening (Mammography, MRI and Ultrasound) Market and Population Forecast to 2021 - Global Analysis

19 Jul 2016  |  Published by:  iGATE Research
Breast cancer is one of the major cause of mortality among women in both the developed and developing world. Early detection remains the primary defense available to patients in preventing the development of life-threatening breast cancer. Breast cancer screening is the regular examination of ...

$ 1,850.00

Read More

Global & USA Cancer Immunotherapy Market Analysis To 2020

15 Jul 2016  |  Published by:  Kelly Scientific Publications
GLOBAL & USA CANCER IMMUNOTHERAPY MARKET ANALYSIS TO 2020: Antibody Drug Conjugates (ADCs), Bispecific Monoclonal Antibodies, Cancer Vaccines, Cytokines, Interferons, Chimeric Antigen Receptor (CAR) T-Cell Therapy, PD-1/PD-L1 inhibitors, Dendritic Cells, Checkpoint Inhibitors, Adopted Cell...

$ 3,800.00

Read More

3D Cell Culture Market by Technology (Scaffold Based, Scaffold Free), Application (Cancer Cell Research, Cell-based Assays/Toxicity Screening), End-Users (Biotechnology & Pharmaceuticals Industries) and Geography - Global Forecast to 2021

05 Jul 2016  |  Published by:  MarketsandMarkets
The global 3D cell culture market size is expected to reach USD 1345.2 million by 2021 from USD 466.8 million in 2016, at a CAGR of 23.6%. The global 3D cell culture market is segmented based on technology, application, end user, and region. The scaffold-based segment is expected to register t...

$ 5,650.00

Read More

Ovarian Cancer-Pipeline Insights, 2016

04 Jul 2016  |  Published by:  DelveInsight
DelveInsight’s, “Ovarian Cancer -Pipeline Insights, 2016”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under the category of Ova...

$ 2,250.00

Read More

Estrogen Receptor Positive (ER+) Breast Cancer-Pipeline Insights, 2016

04 Jul 2016  |  Published by:  DelveInsight
DelveInsight’s, “Estrogen Receptor Positive (ER+) Breast Cancer-Pipeline Insights, 2016”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fa...

$ 1,750.00

Read More

Estrogen Receptor Positive (ER+) Breast Cancer - Market Insights, Epidemiology and Market Forecast-2023-United States

04 Jul 2016  |  Published by:  DelveInsight
DelveInsight’s “Estrogen Receptor Positive (ER+) Breast Cancer - Market Insights, Epidemiology and Market Forecast-2023- US” Reports provides an overview of the disease and global market size of the Estrogen Receptor Positive (ER+) Breast Cancer for the United States. ...

$ 3,250.00

Read More

Ovarian Cancer - Market Insights, Epidemiology and Market Forecast-2020-US

04 Jul 2016  |  Published by:  DelveInsight
DelveInsight’s “Ovarian Cancer - Market Insights, Epidemiology and Market Forecast-2020- US” Reports provides an overview of the disease and global market size of the Ovarian Cancer for the United States. It also includes global historical and forecasted epidemiological d...

$ 3,250.00

Read More

Estrogen Receptor Positive (ER+) Breast Cancer - Treatment Landscape & Competitive Analysis, 2016

04 Jul 2016  |  Published by:  DelveInsight
DelveInsight’s, “Estrogen Receptor Positive (ER+) Breast Cancer - Treatment Landscape & Competitive Analysis, 2016”, report provides comprehensive insights about the treatment landscape across this indication. This report also provides the deep understanding of the...

$ 2,450.00

Read More

Ovarian Cancer - Treatment Landscape & Competitive Analysis, 2016

04 Jul 2016  |  Published by:  DelveInsight
DelveInsight’s, “Ovarian Cancer - Treatment Landscape & Competitive Analysis, 2016”, report provides comprehensive insights about the treatment landscape across this indication. This report also provides the deep understanding of the stages of the ovarian cancer, e...

$ 2,450.00

Read More

US Market Report for Prostate Cancer Treatment Devices 2016 - MedCore

01 Jul 2016  |  Published by:  iData Research Inc
Unlike other cancer treatments, brachytherapy has a history that spans over a century. In 1901, Pierre Curie, a physicist from France, first suggested that radiation could be used to treat cancer to one of his colleagues, a doctor named Henri-Alexandre Danlos. Dr. Danlos tested the idea and fo...

$ 4,995.00

Read More

Global Cancer Diagnostics Market: Trends, Opportunities and Forecasts (2016-2021) (By Type: Imaging Tests, Endoscopy, Biopsy, Tumor Marker; By Imaging Tests Sub-Type: MRI, Ultrasound, PET-CT Scan, Mammography; By Region: North America, Latin America, APAC, Europe, MEA)

01 Jul 2016  |  Published by:  Azoth Analytics
Rising incidences of cancer owing to unhealthy food habits and sedentary lifestyle coupled with the growing technological advancements has resulted in the growth of global cancer diagnostics market Market for cancer diagnostics is growing at a steady pace due to higher incidences of cancer am...

$ 2,400.00

Read More

Global Non-Small Cell Lung Cancer Partnering 2010 to 2016

01 Jul 2016  |  Published by:  CurrentPartnering
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world’s leading healthcare companies. • Trends in partnering deals • Top deals by value • Deals list...

$ 1,495.00

Read More

Global Bladder Cancer Partnering 2010 to 2016

01 Jul 2016  |  Published by:  CurrentPartnering
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world’s leading healthcare companies. • Trends in partnering deals • Top deals by value • Deals list...

$ 1,495.00

Read More

Global Brain Cancer Partnering 2010 to 2016

01 Jul 2016  |  Published by:  CurrentPartnering
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world’s leading healthcare companies. • Trends in partnering deals • Top deals by value • Deals list...

$ 1,495.00

Read More
Total 1039 records.